Octreotide to treat postoperative chylothorax after cardiac operations in children

Ann Thorac Surg. 2001 Nov;72(5):1740-2. doi: 10.1016/s0003-4975(01)02581-4.

Abstract

Chylothorax after pediatric cardiac operations is associated with significant morbidity and increased hospitalization. An octreotide (a synthetic somatostatin analogue) infusion (1 to 4 microg/kg per hour) with medium-chain triglyceride diet or parenteral nutrition was used in 4 pediatric cardiac surgical patients after chylothorax was diagnosed. Resolution followed within 5 days in all without recurrence, while on a normal diet.

Publication types

  • Case Reports

MeSH terms

  • Cardiac Surgical Procedures / adverse effects*
  • Child, Preschool
  • Chylothorax / drug therapy*
  • Chylothorax / etiology
  • Humans
  • Male
  • Octreotide / therapeutic use*

Substances

  • Octreotide